Ordóñez, N G <br/><br/>
Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.  [electronic resource] 

 -  American journal of clinical pathology  Jan 1998 
 - 85-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0002-9173 
<br/><br/><label>Standard No.: </label>10.1093/ajcp/109.1.85  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnosis<br/>Antibodies, Monoclonal<br/>Antigens, Neoplasm--analysis<br/>Antigens, Surface--analysis<br/>Carcinoma, Squamous Cell--diagnosis<br/>Carcinoma, Transitional Cell--diagnosis<br/>Diagnosis, Differential<br/>Epithelium--immunology<br/>Humans<br/>Immunohistochemistry<br/>Lung Neoplasms--diagnosis<br/>Mesothelioma--diagnosis<br/>Pleural Neoplasms--diagnosis